SCHEMBL14007339

SCHEMBL14007339

CCCCOc1ccc(NC(=O)c2sc(S(C)(=O)=O)c3c2CC(C)(C)CC3=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.47
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HTT P42858 1/20 0.44
ALDH1A1 P00352 1/20 0.43
PKM P14618 1/20 0.43
LRRK2 Q5S007 1/20 0.43
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
EHMT2 Q96KQ7 2/20 0.41
TP53 P04637 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14007322 0.82 LRRK2 (0.44) MAPTALDH1A1PKMLRRK2LMNA
SCHEMBL4927165 0.77 ALDH1A1 (0.50) MAPTHPGDHSD17B10KDM4EHTT
SCHEMBL14007311 0.73 POLB (0.44) MAPTHPGDKDM4EHTTALDH1A1
SCHEMBL4923124 0.72 LRRK2 (0.45) MAPTKDM4EALDH1A1PKMLRRK2
SCHEMBL4917837 0.70 ALDH1A1 (0.43) ALDH1A1PKMLRRK2LMNANPC1
SCHEMBL4919003 0.69 LRRK2 (0.46) MAPTHPGDHSD17B10KDM4EHTT
SCHEMBL4918991 0.69 ALDH1A1 (0.51) MAPTHSD17B10KDM4EALDH1A1PKM
SCHEMBL4924480 0.68 LRRK2 (0.47) MAPTKDM4EALDH1A1PKMLRRK2
SCHEMBL4918837 0.67 LMNA (0.48) MAPTHSD17B10KDM4EHTTALDH1A1
SCHEMBL5735016 0.67 BUB1 (0.43) MAPTHPGDHSD17B10KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists GLP1R, GIPR, GCGR MAPT 4242/4885HPGD 1769/4885HSD17B10 1766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.